Approval to Vaccines 'Turning Point' in India's Fight Against Covid-19: Niti Aayog

India's drug regulator DCGI on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

from Top Business News- News18.com https://ift.tt/3rOP36B

• Tweet
• Share
• Share
• Share
• Share